Which supplements increase estrogen? What herbal products actually do

Most supplements marketed as “estrogen-boosting” do not reliably raise estradiol levels. Some plant compounds may still affect symptoms by binding to estrogen receptors or influencing other signaling pathways. The useful starting point is therefore the specific problem, rather than a promise of general “hormonal balance”: are you dealing with hot flashes, premenstrual symptoms, or a diagnosed hormonal condition?

What phytoestrogens and herbal preparations actually do

Phytoestrogens from soy and red clover

Phytoestrogens are plant compounds whose structure allows them to bind to estrogen receptors. Among the best studied are the soy isoflavones genistein and daidzein, and biochanin A and formononetin from red clover. Their effects depend on the receptor type, the tissue, and the surrounding hormonal environment, among other factors.

A 2025 meta-analysis of 40 randomized trials involving 3,285 participants found no statistically significant change in estradiol or FSH with soy isoflavones in postmenopausal women. An improvement in hot flashes therefore does not automatically mean the body has started producing more estrogen.

Selective receptor binding is biologically interesting. It does not, however, justify a simple promise that a supplement will produce desirable effects in bone while protecting every other tissue from hormonal influences.

Black cohosh is not plant-based estradiol

Black cohosh is known botanically as Actaea racemosa, also called Cimicifuga racemosa. Certain extracts are used for menopausal symptoms. Its precise mechanism is not fully understood. Proposed explanations include effects on serotonergic pathways, which involve the chemical messenger serotonin.

Black cohosh is therefore not a plant version of estradiol. Whether it relieves symptoms is a separate clinical question, and the particular extract matters.

Dong quai: traditional use and limited clinical evidence

Dong quai, the root of Angelica sinensis, is used in traditional Chinese medicine for various menstrual complaints. Traditional experience and effectiveness demonstrated in controlled clinical studies are different kinds of evidence.

In a placebo-controlled study of postmenopausal women, dong quai alone showed neither a convincing estrogenic effect nor better symptom relief than placebo. Traditional preparations often contain several herbs. Their results cannot automatically be attributed to one ingredient.

Chasteberry and hormonal regulation

Vitex agnus-castus, commonly called chasteberry, has mainly been studied for premenstrual symptoms. Certain constituents can affect dopamine-related signaling pathways and, through them, prolactin regulation. Its action should not be understood as directly raising estrogen levels.

Life stage matters here: evidence for a product in PMS does not establish that it is a suitable treatment after menopause. New changes in menstrual cycles can also have several possible causes.

How these products may act in the body

Binding to estrogen receptors

Estrogen receptors include alpha and beta types. In experimental studies, genistein preferentially binds to the beta receptor. The distribution of these receptors and their associated signaling pathways differ between tissues.

Phytoestrogens act much more weakly than estradiol in many experimental systems. Frequently quoted differences of about 100-fold to 10,000-fold in potency depend heavily on the compound, receptor, and measurement method. They are not a conversion table for turning a herbal capsule into an equivalent hormone dose.

Communication between the brain, pituitary gland, and ovaries

The hypothalamus, pituitary gland, and ovaries communicate through hormonal signals. As ovarian function declines during the menopausal transition, this feedback system changes. FSH can rise; estradiol may initially fluctuate considerably before settling at a persistently lower level.

Soy isoflavones do not reset this system to its premenopausal state. That helps explain why symptoms and blood test results may change differently. An unchanged estradiol result does not rule out a subjective improvement, but it does not establish what caused the improvement either.

Bones and cardiovascular health

Some studies of soy isoflavones report small changes in bone density or markers of bone metabolism. An effect on a measurement is not the same as a demonstrated reduction in fractures. For someone at increased risk of osteoporosis, established prevention and treatment options belong in the decision.

Researchers also study blood-vessel function and blood lipids. Biological plausibility provides a reason to investigate; it is not enough to promise that an isoflavone supplement prevents heart attacks or strokes.

Chemical messengers in the nervous system

Effects on serotonin- and GABA-related processes have been proposed for black cohosh, kudzu, and licorice root. Such mechanisms might help explain how symptoms could change without an increase in estradiol.

That does not make the plants interchangeable. Licorice root, in particular, can cause clinically relevant adverse effects, including changes in blood pressure and potassium balance. An interesting laboratory finding is not yet a recommendation for self-treatment.

What the clinical studies show

Soy isoflavones

A 2015 meta-analysis found a relatively small average reduction in hot-flash frequency with phytoestrogens, including soy isoflavones. A 2013 Cochrane review covering 43 trials did not reach a clear overall conclusion of effectiveness, although it identified promising signals for certain genistein concentrates.

These findings are not necessarily a complete contradiction: the analyses combined different preparations and trials. They show why a possible response to one product cannot be assumed for every isoflavone capsule. The more recent analysis of hormone levels also reinforces that these products are not hormone replacement.

Red clover

Red clover has been studied for menopausal symptoms and vascular processes. A small 2022 randomized crossover study examined a fermented extract in 10 early postmenopausal women over two weeks. It reported a reduction in the vascular inflammation marker VCAM-1, while several muscle-related measures did not change.

That answers a different question from whether a product reduces hot flashes or prevents cardiovascular disease over the long term. Findings on symptom relief are inconsistent. Differences in isoflavone content and how the body processes it may contribute.

Black cohosh

Some studies of particular extracts report improvements in menopausal symptoms; others are less convincing. The HALT study assessed hormone levels as well as vaginal and endometrial findings. The absence of marked estrogenic changes provides information about the action of the preparations tested, but is not, by itself, evidence of good symptom relief.

A lack of estrogenic activity also does not automatically make a product suitable for everyone who cannot use hormone therapy. The reasons a particular treatment is unsuitable need to be considered individually.

Dong quai

The 1997 placebo-controlled trial found no advantage for dong quai alone in postmenopausal symptoms. For herbal mixtures, the ingredients, doses, and quality of the particular study remain important. A benefit from a mixture does not establish that every plant in it works.

Chasteberry

Meta-analyses from 2017 and 2019 suggest that certain Vitex preparations may relieve premenstrual symptoms. The studies vary in quality and formulation. They mainly concern PMS and should not be read as evidence of a general estrogen-boosting effect or an established treatment after menopause.

Doses, timing, and product formulation

Soy isoflavones

Amounts commonly investigated are around 40–80 mg of isoflavones a day. Check whether a label refers to the actual isoflavone content or simply the total amount of extract. Studies usually assessed changes in symptoms over several weeks, often four to twelve.

A particular amount does not guarantee a benefit. Instructions about taking a supplement with meals also need to be considered for the specific product, rather than assuming a universal rule for maximizing absorption.

Red clover

Studies have also often used 40–80 mg of isoflavones a day. The proportions of biochanin A and formononetin, and how the extract is processed, may differ. Results from a fermented study preparation cannot therefore be transferred to another product on the basis of its total milligram amount alone.

Black cohosh

Depending on the extract, amounts such as 40–80 mg a day are sometimes cited. Products differ in extract quantity, extraction solvent, and the ratio of plant material to finished extract. Comparing milligrams alone can therefore be misleading. What matters is the specific licensed or studied preparation and its instructions for use; a license in one jurisdiction does not establish approval everywhere.

Dong quai

Traditional uses include around 3–15 g of dried root a day, prepared as a decoction or in other forms. This broad range is not a recommendation derived from controlled trials for treating menopausal symptoms. There are insufficient data to establish an optimal amount.

Chasteberry

Certain dry extracts are commonly used at 20–40 mg a day. Here, too, the definition of the extract matters. PMS studies assess changes over several cycles. Taking a product in the morning is not evidence that it thereby raises estrogen in a targeted way.

When extra caution is worthwhile

Concentrated herbal extracts can cause side effects and interact with medicines. If you have a hormone-sensitive tumor or take tamoxifen or an aromatase inhibitor, discuss their use with your treatment team. Findings about ordinary soy foods cannot simply be applied to highly concentrated isoflavone supplements. Conversely, a warning about a supplement is not a general prohibition on eating soy.

Rare cases of liver injury have been reported with products containing black cohosh, although the link to the product is not always clear. Existing liver disease and suspicious symptoms therefore matter before and during use. Yellowing of the skin, dark urine, or other possible signs of liver problems warrant medical assessment.

Soy can affect levothyroxine absorption. If you take thyroid hormone, discuss substantial changes in soy foods or supplements and follow medication-specific timing instructions. Blood thinners, previous vascular events, endometriosis, or fibroids may also warrant individual review. Theoretical receptor effects alone do not predict that every person with these conditions will get worse.

Why responses may differ

Gut bacteria further process isoflavones. Some people convert daidzein into the metabolite equol; others produce little. This may influence the response. An equol test is not an established simple selection tool that reliably predicts treatment success.

When blood tests may help

Estradiol and FSH can help assess ovarian function in particular circumstances. During the menopausal transition, however, both can fluctuate considerably. A single estradiol result or a fixed FSH cutoff of 30–40 IU/L therefore does not reliably establish the hormonal life stage in every situation.

LH provides further information about hormonal regulation. SHBG binds sex hormones and affects their availability. Neither is a routine test of whether a herbal product is working. TSH may be useful when symptoms suggest a thyroid cause or when thyroid treatment needs reassessment.

The need for testing depends on age, menstrual history, symptoms, and the medical context. Typical menopausal symptoms do not automatically call for a broad hormone panel before and after every supplement. A symptom diary can often answer the more relevant question directly: are hot flashes, sleep, or the burden on daily life actually improving?

Make the decision around your symptoms

A clearly defined goal makes selection easier and keeps a laboratory number from becoming an end in itself. Someone hoping for fewer nighttime hot flashes can track their frequency and impact over several weeks. If there is no noticeable improvement, or side effects occur, continued use should be reassessed.

For troublesome symptoms, it is also worth discussing the full range of effective treatments. Herbal products are one category to consider, but not the only one, and suitability does not depend simply on whether something is marketed as natural.

Frequently asked questions

Do phytoestrogens raise estrogen levels?

On average, studies of soy isoflavones in postmenopausal women do not show a meaningful increase in estradiol. These compounds can act at receptors without reproducing hormone therapy.

Is black cohosh suitable after breast cancer?

That should be discussed with the oncology team. There are observational data and experimental indications of possible drug interactions, including effects on tamoxifen metabolism. The absence of a clearly estrogenic effect is not enough to establish safety.

When might I notice an improvement?

Many trials assess symptoms after four to twelve weeks. Agreeing on a timeframe and a specific symptom goal in advance can help determine whether continuing is worthwhile.

Are soy isoflavones safe over the long term?

Studies lasting up to three years provide reassuring findings on some safety measures in the postmenopausal groups studied. In one trial involving 224 women, 80 or 120 mg a day did not increase endometrial thickness relative to placebo. These findings do not answer every question about every dose or existing condition. High-dose extracts should be considered separately from ordinary soy foods.

Can I combine several products?

An additional benefit cannot be assumed. More ingredients create more opportunities for interactions and make it harder to identify what caused a benefit or a side effect.

Do they help prevent bone loss?

Soy isoflavones show possible small effects on certain bone measurements. For treating osteoporosis or a high fracture risk, other interventions studied specifically for those problems are more important.

Do I need a hormone test first?

Not necessarily. Testing should follow the medical question. Single measurements can be misleading during the menopausal transition and are not a prerequisite for every symptom-focused decision.

How do phytoestrogens differ from bioidentical hormones?

Phytoestrogens are plant molecules that may act on receptors. Body-identical estradiol or progesterone, by contrast, is chemically identical to the corresponding human hormone and is used in medicines. The benefits, doses, and risks of these treatments need to be assessed in their own right.

References

• Viscardi G, Back S, Ahmed A, Yang S, Mejia SB, Zurbau A, Khan TA, Selk A, Messina M, Kendall CW, Jenkins DJ, Sievenpiper JL, Chiavaroli L (2025). Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in nutrition (Bethesda, Md.), 16(1), 100327. https://doi.org/10.1016/j.advnut.2024.100327 — Source
• Ruhlen RL, Sun GY, Sauter ER (2008). Black Cohosh: Insights into its Mechanism(s) of Action. Integrative medicine insights, 3, 21-32. https://pubmed.ncbi.nlm.nih.gov/21614156/ — Source
• Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B (1997). Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertility and sterility, 68(6), 981-6. https://doi.org/10.1016/s0015-0282(97)00397-x — Source
• Manas ES, Xu ZB, Unwalla RJ, Somers WS (2004). Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure (London, England : 1993), 12(12), 2197-207. https://doi.org/10.1016/j.str.2004.09.015 — Source
• Patisaul HB, Jefferson W (2010). The pros and cons of phytoestrogens. Frontiers in neuroendocrinology, 31(4), 400-19. https://doi.org/10.1016/j.yfrne.2010.03.003 — Source
• Barańska A, Kanadys W, Bogdan M, Stępień E, Barczyński B, Kłak A, Augustynowicz A, Szajnik M, Religioni U (2022). The Role of Soy Isoflavones in the Prevention of Bone Loss in Postmenopausal Women: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. Journal of clinical medicine, 11(16). https://doi.org/10.3390/jcm11164676 — Source
• Hajirahimkhan A, Dietz BM, Bolton JL (2013). Botanical modulation of menopausal symptoms: mechanisms of action?. Planta medica, 79(7), 538-53. https://doi.org/10.1055/s-0032-1328187 — Source
• Chen MN, Lin CC, Liu CF (2015). Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric : the journal of the International Menopause Society, 18(2), 260-9. https://doi.org/10.3109/13697137.2014.966241 — Source
• Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J (2013). Phytoestrogens for menopausal vasomotor symptoms. The Cochrane database of systematic reviews, 2013(12), CD001395. https://doi.org/10.1002/14651858.CD001395.pub4 — Source
• Wickham KA, Nørregaard LB, Oxfeldt M, Cheung SS, Gliemann L, Hansen M, Hellsten Y (2022). Short-Term Supplementation With Fermented Red Clover Extract Reduces Vascular Inflammation in Early Post-menopausal Women. Frontiers in cardiovascular medicine, 9, 826959. https://doi.org/10.3389/fcvm.2022.826959 — Source
• Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K (2008). Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause (New York, N.Y.), 15(1), 51-8. https://pubmed.ncbi.nlm.nih.gov/18257142/ — Source
• Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ (2017). The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. American journal of obstetrics and gynecology, 217(2), 150-166. https://doi.org/10.1016/j.ajog.2017.02.028 — Source
• Csupor D, Lantos T, Hegyi P, Benkő R, Viola R, Gyöngyi Z, Csécsei P, Tóth B, Vasas A, Márta K, Rostás I, Szentesi A, Matuz M (2019). Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complementary therapies in medicine, 47, 102190. https://doi.org/10.1016/j.ctim.2019.08.024 — Source
• Muqeet Adnan M, Khan M, Hashmi S, Hamza M, AbdulMujeeb S, Amer S (2014). Black cohosh and liver toxicity: is there a relationship?. Case reports in gastrointestinal medicine, 2014, 860614. https://doi.org/10.1155/2014/860614 — Source
• Gatta E, Maltese V, Cavadini M, Anelli V, Bambini F, Buoso C, Facondo P, Pirola I, Delbarba A, Cappelli C (2023). Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(11), 897-901. https://doi.org/10.1016/j.eprac.2023.08.009 — Source
• Iino C, Shimoyama T, Iino K, Yokoyama Y, Chinda D, Sakuraba H, Fukuda S, Nakaji S (2019). Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production. Nutrients, 11(2). https://doi.org/10.3390/nu11020433 — Source
• Rostock M, Fischer J, Mumm A, Stammwitz U, Saller R, Bartsch HH (2011). Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 27(10), 844-8. https://doi.org/10.3109/09513590.2010.538097 — Source
• Li J, Gödecke T, Chen SN, Imai A, Lankin DC, Farnsworth NR, Pauli GF, van Breemen RB, Nikolić D (2011). In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4. Xenobiotica; the fate of foreign compounds in biological systems. https://doi.org/10.3109/00498254.2011.603385 — Source
• Alekel DL, Genschel U, Koehler KJ, Hofmann H, Van Loan MD, Beer BS, Hanson LN, Peterson CT, Kurzer MS (2015). Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women. Menopause (New York, N.Y.), 22(2), 185-97. https://doi.org/10.1097/GME.0000000000000280 — Source
• Wei P, Liu M, Chen Y, Chen DC (2012). Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pacific journal of tropical medicine, 5(3), 243-8. https://doi.org/10.1016/S1995-7645(12)60033-9 — Source